Dave Denton

Pfizer reiterated its 2026 revenue outlook of $59.5‑$62.5 billion and adjusted EPS range of $2.80‑$3.00 per share. The guidance, first issued on Dec 16 2025, was reconfirmed during the Q1 earnings cal